The Moldovan Competition Authority prosecutes suppliers of pharmaceutical products for the failure to supply to the public health care institutions (Esculap)

On 21 April 2016 the Moldovan Competition Authority (CC) [1] has issued an infringement decisions against six suppliers of various pharmaceutical products for their failure to deliver the agreed quantities of medicines to the public health care institutions. The fines imposed on the undertakings concerned exceeded MDL 17 million. In February 2015 the Parliamentary Commission for social protection, health care and family [2] initiated an investigation concerning the failures of the suppliers of medicines to fulfil their contractual obligations and deliver various pharmaceutical products to the public healthcare institutions. The parliamentary investigation involved the Ministry of Healthcare, [3] the CC, the Medicines and Medical Devices

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • University of Macau - Faculty of Law (Macau)

Quotation

Alexandr Svetlicinii, The Moldovan Competition Authority prosecutes suppliers of pharmaceutical products for the failure to supply to the public health care institutions (Esculap), 21 April 2016, e-Competitions Notion of dominance, Art. N° 80055

Visites 245

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues